CI-1002 is a novel anticholinesterase and muscarinic antagonist that can be used to treat cognitive dysfunction in AD with fewer peripheral side effects.

149028-28-4

C13H14Cl2N2

269.17

UNII-7U374ZW3YB;PD-142676;CI-1002

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years